Market Overview

Benzinga's Top Downgrades

Related ATU
#PreMarket Primer: Thursday, June 19: US Stocks Soar As Fed Recommits To Accommodative Policy
S&P 500 Back And Fill Coming Amid Bullish Stats
Related XYL
Will Xylem (XYL) Miss Earnings Estimates in This Quarter?
Xylem To Sell United Kingdom-Based Oil & Gas Valves Business To Rotork For Roughly $25M

Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.

Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.

Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.

JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.

Latest Ratings for ATU

DateFirmActionFromTo
Jun 2014CitigroupMaintainsNeutral
Apr 2014SunTrust Robinson HumphreyUpgradesNeutralBuy
Mar 2014JefferiesMaintainsBuy

View More Analyst Ratings for ATU
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ATU + ANTH)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters